Rare diseases
Investigational molecules
Locations
Back to Spain445 clinical trials in Salamanca, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Safety and Efficacy of MK-1045 with Tocilizumab in Patients with CLL/SLL
SpainStudy of elranatamab, mezigdomide and dexamethasone in patients with relapsed/refractory multiple myeloma
SpainSpainStudy of Elritercept (TAK‑226) with Ruxolitinib vs Placebo in Patients with Myelofibrosis and Anemia on Ruxolitinib Therapy
SpainA Phase III Study of AZD0120 versus melphalan hydrochloride with lenalidomide maintenance in transplant‑eligible adults with newly diagnosed multiple myeloma
SpainEfficacy and safety of house dust mite allergoid (Dermatophagoides farinae, D. pteronyssinus, aluminium hydroxide) in people with moderate to severe house dust mite allergy
SpainPhase II study of inotuzumab ozogamicin to prevent relapse in adult high‑risk acute lymphoblastic leukaemia patients after allogeneic stem cell transplant
SpainSpainEvaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis
SpainEvaluating venetoclax with drug combination in relapsed/refractory T‑cell acute lymphoblastic leukemia patients
SpainA study to evaluate the safety and effectiveness of azetukalner in patients with bipolar depression
SpainStudy of mesenchymal stromal cells expressing CXCR4 and IL-10 for patients with acute Graft Versus Host Disease who do not respond to steroids or ruxolitinib
SpainThe busiest research cities in the country
What the registry says about research in the country
Advanced studies focusing on various types of lymphomas and leukemias, including innovative combination therapies for mantle cell lymphoma and chronic myeloid leukemia. Multiple trials are evaluating novel treatment approaches for both newly diagnosed and refractory cases.
Research includes promising treatments for pancreatic adenocarcinoma and advanced breast cancer.
Investigations into preventing and treating respiratory syncytial virus infections, with particular focus on vaccine development for older adults. Studies aim to understand immune responses and evaluate preventive strategies.
Clinical trials emphasize protection for vulnerable populations against respiratory infections.
Research addressing chronic spontaneous urticaria and autoimmune conditions, including innovative treatments for systemic sclerosis. Studies evaluate new therapeutic approaches for inflammatory conditions.
Trials focus on improving patient outcomes through targeted immunological interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
